1. Home
  2. LEGH vs IMMX Comparison

LEGH vs IMMX Comparison

Compare LEGH & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LEGH

Legacy Housing Corporation (TX)

HOLD

Current Price

$24.57

Market Cap

528.7M

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$8.22

Market Cap

629.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEGH
IMMX
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
528.7M
629.3M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
LEGH
IMMX
Price
$24.57
$8.22
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$25.00
$19.20
AVG Volume (30 Days)
70.1K
1.4M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$164,567,000.00
N/A
Revenue This Year
$11.90
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$53.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.29
$1.94
52 Week High
$29.45
$11.61

Technical Indicators

Market Signals
Indicator
LEGH
IMMX
Relative Strength Index (RSI) 62.57 39.60
Support Level $20.66 $8.10
Resistance Level $29.45 $10.61
Average True Range (ATR) 1.03 0.74
MACD 0.04 -0.09
Stochastic Oscillator 77.43 21.93

Price Performance

Historical Comparison
LEGH
IMMX

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: